Neupro can treat Parkinson's disease and Restless Legs Syndrome

Share this article:
Neupro can treat Parkinson's disease and Restless Legs Syndrome
Neupro can treat Parkinson's disease and Restless Legs Syndrome

UCB has announced the launch of Neupro in the United States for the treatment of Parkinson's disease and restless legs syndrome. The once-daily patch provides continuous delivery of the dopamine agonist rotigotine. The Food & Drug Administration approved the medication in April. Parkinson's affects about one million Americans, while up to 23 million Americans may be afflicted by Restless Leg Syndrome.

Share this article:
close

Next Article in Products

More in Products

LeadingAge's CAST releases medication management tools

LeadingAge's Center for Aging Services Technologies release new tools last week to help long-term care providers identify the best medication management product.

Butler Mobility updates paint colors for platform lifts

Butler Mobility updates paint colors for platform lifts

Butler Mobility has widened the spectrum of paint color choices for its Incline Platform Lifts line.

NeuroMetrix releases pain management system

NeuroMetrix releases pain management system

NeuroMetrix Inc. has created the SENSUS™ Pain Management System, a wearable neurostimulation technology developed for chronic neuropathic pain, including painful diabetic neuropathy.